Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19

J Antimicrob Chemother. 2020 Sep 1;75(9):2708-2710. doi: 10.1093/jac/dkaa223.

Nathan Peiffer-Smadja^{1

2}, François-Xavier Lescure^{1

3}, Erwan Sallard⁴, Philippe Ravaud⁵, Bruno Vegreville⁶, Jean-David Zeitoun^{5

6}

¹ Université de Paris, IAME, INSERM, F-75018 Paris, France.
² National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
³ Department of Infectious and Tropical Diseases, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018 Paris, France.
⁴ École normale supérieure de Paris, 45 rue d'Ulm, 75005 Paris, France.
⁵ U1153, Epidemiology and Biostatistics Sorbonne, Paris Cite Research Center (CRESS), Methods of therapeutic evaluation of chronic diseases team (METHODS), INSERM, Université Paris Descartes, Paris, Île-de-France, France.
⁶ Inato, Paris, France.

No abstract available

Publication types